19-10986542-G-T

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2

The NM_001387283.1(SMARCA4):​c.709G>T​(p.Gly237Cys) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G237S) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

SMARCA4
NM_001387283.1 missense

Scores

1
8
9

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 6.66

Publications

0 publications found
Variant links:
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
SMARCA4 Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
  • intellectual disability, autosomal dominant 16
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • rhabdoid tumor predisposition syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • uterine corpus sarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • familial rhabdoid tumor
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMARCA4NM_001387283.1 linkc.709G>T p.Gly237Cys missense_variant Exon 4 of 36 ENST00000646693.2 NP_001374212.1
SMARCA4NM_003072.5 linkc.709G>T p.Gly237Cys missense_variant Exon 4 of 35 ENST00000344626.10 NP_003063.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMARCA4ENST00000646693.2 linkc.709G>T p.Gly237Cys missense_variant Exon 4 of 36 NM_001387283.1 ENSP00000495368.1
SMARCA4ENST00000344626.10 linkc.709G>T p.Gly237Cys missense_variant Exon 4 of 35 1 NM_003072.5 ENSP00000343896.4
SMARCA4ENST00000643549.1 linkc.709G>T p.Gly237Cys missense_variant Exon 4 of 35 ENSP00000493975.1
SMARCA4ENST00000541122.6 linkc.709G>T p.Gly237Cys missense_variant Exon 5 of 35 5 ENSP00000445036.2
SMARCA4ENST00000643296.1 linkc.709G>T p.Gly237Cys missense_variant Exon 4 of 34 ENSP00000496635.1
SMARCA4ENST00000644737.1 linkc.709G>T p.Gly237Cys missense_variant Exon 4 of 34 ENSP00000495548.1
SMARCA4ENST00000589677.5 linkc.709G>T p.Gly237Cys missense_variant Exon 5 of 35 5 ENSP00000464778.1
SMARCA4ENST00000643995.1 linkc.121G>T p.Gly41Cys missense_variant Exon 1 of 32 ENSP00000496004.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1388384
Hom.:
0
Cov.:
34
AF XY:
0.00
AC XY:
0
AN XY:
685196
African (AFR)
AF:
0.00
AC:
0
AN:
31578
American (AMR)
AF:
0.00
AC:
0
AN:
35658
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25122
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35728
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79158
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
38942
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5694
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1078602
Other (OTH)
AF:
0.00
AC:
0
AN:
57902
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary cancer-predisposing syndrome Uncertain:1
Feb 19, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.G237C variant (also known as c.709G>T), located in coding exon 3 of the SMARCA4 gene, results from a G to T substitution at nucleotide position 709. The glycine at codon 237 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Missense and in-frame variants in SMARCA4 are known to cause neurodevelopmental disorders; however, such associations with rhabdoid tumor predisposition syndrome including small cell carcinoma of the ovary-hypercalcemic type (SCCOHT) are exceedingly rare (Kosho T et al. Am J Med Genet C Semin Med Genet. 2014 Sep;166C(3):262-75; Jelinic P et al. Nat Genet. 2014 May;46(5):424-6). Based on the supporting evidence, the association of this alteration with Coffin-Siris syndrome is unknown; however, the association of this alteration with rhabdoid tumor predisposition syndrome is unlikely.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Uncertain
0.084
D
BayesDel_noAF
Benign
-0.12
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.38
T;.;T;.;.;.;.;.;.;.;T;.;.;.;.;.;T;T
Eigen
Benign
0.040
Eigen_PC
Benign
0.075
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.0
.;D;.;.;.;.;D;.;.;.;D;.;D;D;D;D;D;D
M_CAP
Uncertain
0.27
D
MetaRNN
Uncertain
0.70
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
0.31
D
MutationAssessor
Benign
1.1
L;.;.;.;L;L;.;L;L;L;L;L;L;L;L;L;.;.
PhyloP100
6.7
PrimateAI
Pathogenic
0.87
D
PROVEAN
Benign
-1.4
N;.;.;.;.;.;.;.;.;.;N;.;N;.;N;.;N;N
REVEL
Uncertain
0.47
Sift
Benign
0.031
D;.;.;.;.;.;.;.;.;.;D;.;T;.;T;.;T;T
Sift4G
Uncertain
0.041
D;.;.;.;.;.;.;.;.;.;D;.;D;T;T;T;D;D
Vest4
0.63
ClinPred
0.83
D
GERP RS
3.5
PromoterAI
-0.022
Neutral
Varity_R
0.24
gMVP
0.44
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1555753727; hg19: chr19-11097218; API